{"id":"NCT00121992","sponsor":"Spanish Breast Cancer Research Group","briefTitle":"Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment","officialTitle":"Phase III Randomized Comparing Docetaxel, Doxorubicin and Cyclophosphamide (TAC) vs 5-Fluorouracil, Doxorubicin and Cyclophosphamide (FAC) as Adjuvant Treatment of High Risk Operable Breast Cancer Patients With Negative Axillary Lymph Nodes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1999-07","primaryCompletion":"2010-12-02","completion":"2013-03-06","firstPosted":"2005-07-21","resultsPosted":"2020-12-04","lastUpdate":"2023-04-04"},"enrollment":1060,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Neoplasms"],"interventions":[{"type":"DRUG","name":"Docetaxel","otherNames":["Taxotere"]},{"type":"DRUG","name":"5-fluorouracil","otherNames":["Adrucil"]},{"type":"DRUG","name":"Doxorubicin","otherNames":["adriamycin"]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":["cytoxan"]}],"arms":[{"label":"Arm A: FAC","type":"ACTIVE_COMPARATOR"},{"label":"Arm B: TAC","type":"EXPERIMENTAL"}],"summary":"This is a prospective, non-blinded randomized phase III trial. Patients will be post-surgically stratified at inclusion first according to the participating institution, then according to menopausal status and will be randomly assigned to receive either:\n\n* TAC: Docetaxel 75 mg/m2 as a 1 hour intravenous (i.v.) infusion on day 1 every 3 weeks (q3w) in combination with doxorubicin 50 mg/m2 as an i.v. bolus and cyclophosphamide 500 mg/m2 as an i.v. bolus on day 1 every 3 weeks.\n* FAC: 5-fluorouracil 500 mg/m2 as an i.v. bolus on day 1 every 3 weeks in combination with doxorubicin 50 mg/m2 as an i.v. bolus and cyclophosphamide 500 mg/m2 as an i.v. bolus on day 1 every 3 weeks.","primaryOutcome":{"measure":"Disease-free Survival (DFS) Events","timeFrame":"10 years","effectByArm":[{"arm":"Arm A: FAC","deltaMin":127,"sd":null},{"arm":"Arm B: TAC","deltaMin":112,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":19},"locations":{"siteCount":1,"countries":["Spain"]},"refs":{"pmids":["15930421","21121833"],"seeAlso":["http://www.geicam.org"]},"adverseEventsSummary":{"seriousAny":{"events":21,"n":519},"commonTop":["Alopecia","Nausea","Asthenia","Vomiting","Stomatitis"]}}